Enhancing Cardiometabolic Health in Diabetes Care With Incretin-Based Therapies

In this podcast, Jennifer Green, MD, and Jay H. Shubrook, DO, FAAFP, FACOFP, share strategies for integrating incretin-based therapies in type 2 diabetes (T2D) management in the primary care setting, including:

• Importance of moving beyond a glucose-centric approach to T2D care 
• Current evidence for incretin-based therapies in T2D
• Rationale for integrating these therapies into the primary care setting
• Shared decision-making strategies to discuss optimal T2D treatment options with patients
• Timing for endocrinology referral

Presenters:

Jennifer Green, MD Professor of Medicine Division of Endocrinology Duke Clinical Research Institute Duke University School of Medicine Durham, North Carolina

Jay H. Shubrook, DO, FAAFP, FACOFP Professor, Diabetologist Department of Clinical Sciences and Community Medicine Touro University California, College of Osteopathic Medicine Vallejo, California

Full program link: https://bit.ly/4uSKCqv

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Multispecialty Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.